flat bone
|
UBERON_0010428 |
[A bone that is shaped as a broad flat plate and composed of two thin layers of compact tissue enclosing between them a variable quantity of cancellous tissue, which is the location of red bone marrow.] |
high nuclear/cytoplasmic ratio
|
PATO_0040072 |
[A quality inhering in a cell by virtue of the cell having a high nuclear/cytoplasmic ratio.] |
cellular quality
|
PATO_0001396 |
[A monadic quality of continuant that exists at the cellular level of organisation.] |
thermoplastic
|
PATO_0040070 |
[A physical quality inhering in a bearer by virtue of the bearer's disposition to deform by heating.] |
physical quality
|
PATO_0001018 |
[A quality of a physical entity that exists through action of continuants at the physical level of organisation in relation to other entities.] |
nuclear/cytoplasmic ratio
|
PATO_0040071 |
[A quality inhering in a cell by virtue of the ratio between the volume of its nucleus and the volume of its cytoplasm.] |
regulation of growth
|
GO_0040008 |
[Any process that modulates the frequency, rate or extent of the growth of all or part of an organism so that it occurs at its proper speed, either globally or in a specific part of the organism's development.] |
nuclear chromosome
|
GO_0000228 |
[A chromosome that encodes the nuclear genome and is found in the nucleus of a eukaryotic cell during the cell cycle phases when the nucleus is intact.] |
chromosome
|
GO_0005694 |
[A structure composed of a very long molecule of DNA and associated proteins (e.g. histones) that carries hereditary information.] |
positive regulation of myeloid leukocyte mediated immunity
|
GO_0002888 |
[Any process that activates or increases the frequency, rate, or extent of myeloid leukocyte mediated immunity.] |
regulation of myeloid leukocyte mediated immunity
|
GO_0002886 |
[Any process that modulates the frequency, rate, or extent of myeloid leukocyte mediated immunity.] |
positive regulation of leukocyte mediated immunity
|
GO_0002705 |
[Any process that activates or increases the frequency, rate, or extent of leukocyte mediated immunity.] |
oocyte maturation
|
GO_0001556 |
[A developmental process, independent of morphogenetic (shape) change, that is required for an oocyte to attain its fully functional state. Oocyte maturation commences after reinitiation of meiosis commonly starting with germinal vesicle breakdown, and continues up to the second meiotic arrest prior to fertilization.] |
developmental process involved in reproduction
|
GO_0003006 |
[A developmental process in which a progressive change in the state of some part of an organism, germline or somatic, specifically contributes to its ability to form offspring.] |
cell maturation
|
GO_0048469 |
[The cellular developmental process, independent of morphogenetic (shape) change, that is required for a specific cell to attain its fully functional state.] |
developmental maturation
|
GO_0021700 |
[A developmental process, independent of morphogenetic (shape) change, that is required for an anatomical structure, cell or cellular component to attain its fully functional state.] |
cytoskeleton organization
|
GO_0007010 |
[A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures.] |
microtubule-based process
|
GO_0007017 |
[Any cellular process that depends upon or alters the microtubule cytoskeleton, that part of the cytoskeleton comprising microtubules and their associated proteins.] |
negative regulation of myeloid leukocyte mediated immunity
|
GO_0002887 |
[Any process that stops, prevents, or reduces the frequency, rate, or extent of myeloid leukocyte mediated immunity.] |
negative regulation of leukocyte mediated immunity
|
GO_0002704 |
[Any process that stops, prevents, or reduces the frequency, rate, or extent of leukocyte mediated immunity.] |